None listed
Conditions
Brief summary
This study is a single-centre, two (2) groups (ischaemic and haemorrhagic stroke), observational study of participants with a diagnosed stroke whose data would be used to refine the algorithm of the software component of the EMVision brain scanner. No intervention or modification to the usual hospital based treatment of stroke is proposed as part of this trial. The study population will include patients of the Princess Alexandra Hospital, Brisbane, Australia, with stroke symptoms and radiological images of the type and location of the stroke. Patients who are confirmed/diagnosed to have stroke and have diagnostic CT or MRI images for comparison, would be considered for participation in the study. The microwave imaging will not change the standard clinical care, nor be used in clinical nor diagnostic evaluation in this study. A participant’s involvement may last up to approximately 28 days as an inpatient or until discharge (whichever is sooner). The total trial will be conducted over approximately 12 months (including enrolment of up to 30 participants).
Interventions
Once consent is documented, the participant would be further reviewed, and data such as demographics, medical history, vital signs, and NIH Stroke Scale will be collected, and physical exam will be performed. Physical exam, NIH Stroke Scale and vital signs be recorded and are part of triage process or hospital/emergency department acute care standard operating procedure. CT/MRI would be conducted as part of standard diagnostics process of any patients presenting with stroke symptoms. Stroke diagnosis would be made following the results of CT/MRI and whether of haemorrhagic stroke or ischemic stroke will be collected and recorded. The EMV scanner unit consists of a portable headset (a crown housing an array of antennae, with a coupling-fluid filled bladder that inflates gently to make contact with the head), and computer with graphic user interface. Within 72 hour, and ideally as close to the diagnostic scan time as feasible, the EMVision brain scanner will be placed on the participant’s head to acquire the first scan data. Each image acquisition from positioning, scanning and device removal will take approximately 10 minutes. Scanning will be undertaken by a member of the Neurology and/or Intensivist team after extensive training is undertaken and signed off by the Sponsor. Actual image acquisition will take approximately 20 seconds. The participants will be positioned in a semi-recumbent position in the bed for scanning. A pillow will be placed behind the participant’s back to accommodate the head scanner such that the participant is kept as comfortable as possible during the scan. Each EMVision scan will be performed in duplicate, user/performance data will be gathered, and image data recorded from both scans will be analysed for reproducibility/comparison. The participants would be exposed to signal power intensities up to 10 mW which is within Federal Communications Commission standards. These frequencies are used in mobile communication, body scanners and many other daily life applications. The captured signals are then stored and processed using a laptop or tablet and subsequently analysed at the UQ ITT laboratory to generate an image of the head. Follow up scans as above will be collected at approximately days 3-5, 6-8, and during the convalescence period, if clinically acceptable to do so, as deemed by the investigator. No more than five scans will be collected. A participant’s involvement may last up to approximately 28 days as an inpatient or until discharge (whichever is sooner). A patient may be considered as 'completed' if a minimum of one EMVision digital can is conducted and is either followed to 28 days (or discharge, whichever is sooner) or passes away prior.
Sponsors
Study design
Eligibility
Inclusion criteria
1. Adults >=18 years of age. 2. Admitted to hospital with new neurological signs and confirmed diagnosis of stroke supported by conventional brain imaging. 3. Ability to provide informed consent. Participants will provide written informed consent. Where this is not possible, surrogate consent will be obtained. 4. Ability to adhere to study visit schedule and other protocol requirements. 5. Confirmed diagnosis of stroke within 72 hours of admission. 6. Head size deemed suitable for scanning with the EMVision brain scanner.
Exclusion criteria
1. Experiences seizures from onset of stroke, or known history of seizure episodes. 2. Has injury or known medical condition on the head that would not allow the placement of EMVision brain scanner. 3. Is unable to lie still for the duration of the scan. 4. Is not a suitable candidate according to the assessing investigator. 5. Has any metal implants in the head or neck for example stents, aneurism clips, surgical clips, pressure monitors and drains. 6. Is known to be pregnant or lactating.